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Breast cancer susceptibility gene 2 (BRCA2) plays a
key role in DNA damage repair for maintaining
genomic stability. Previous studies have shown that
BRCA2 contains three tandem oligonucleotide/oligo-
saccharide binding folds (OB-folds) that are involved
in DNA binding during DNA double-strand break
repair. However, the molecular mechanism of
BRCA2 in DNA damage repair remains elusive. Unex-
pectedly,we found that theOB-foldsofBRCA2 recog-
nize poly(ADP-ribose) (PAR) and mediate the fast
recruitment of BRCA2 to DNA lesions, which is sup-
pressed by PARP inhibitor treatment. Cancer-associ-
ated mutations in the OB-folds of BRCA2 disrupt the
interaction with PAR and abolish the fast relocation
of BRCA2 to DNA lesions. The quickly recruited
BRCA2 is important for theearly recruitmentof exonu-
clease 1(EXO1) and is involved in DNA end resection,
the first step of homologous recombination (HR).
Thus, these findings uncover a molecular mechanism
by which BRCA2 participates in DNA damage repair.
INTRODUCTION
Human cells encounter numerous environmental and internal
hazards daily. Fortunately, with DNA damage repair systems,
cells faithfully repair DNA lesions for maintaining genomic stabil-
ity. Loss of DNA damage repair pathways induces accumulation
of DNA damage lesions and ultimately leads to genomic insta-
bility and tumorigenesis. Thus, DNA damage repair plays a key
role in tumor suppression, and many DNA damage repair pro-
teins are important tumor suppressors. One typical example is
breast cancer susceptibility gene 2 (BRCA2).
Carriers of germline mutations of BRCA2 are predisposed to
early onset breast and ovarian cancers as well as Fanconi ane-
mia (Howlett et al., 2002; Nathanson et al., 2001; Tavtigian
et al., 1996; Wooster et al., 1995; Wooster and Weber, 2003).
Mutations of BRCA2 are also associated with other types of can-
cer such as prostate and pancreatic cancers (Breast Cancer
Linkage, 1999). Accumulated evidence suggests that BRCA2678 Cell Reports 13, 678–689, October 27, 2015 ª2015 The Authorsplays a key role during DNA damage repair (Scully and Living-
ston, 2000; Venkitaraman, 2002). Cells with BRCA2 mutations
are hypersensitive to crosslinking agents and fail to repair DNA
double-stranded breaks (DSBs) via homologous recombination
(HR) pathway (Chen et al., 1999; Moynahan et al., 2001; Patel
et al., 1998), an error-free repair mechanism for DSBs. BRCA2
has been revealed to facilitate the relocation of RAD51, a key
HR recombinase, to DNA lesions and promote the formation of
RAD51 nucleoprotein filament, which is required for a strand in-
vasion step during HR repair (Davies et al., 2001; Jensen et al.,
2010; Liu et al., 2010; Powell et al., 2002; Thorslund et al.,
2010; Yang et al., 2005a; Yuan et al., 1999).
The human BRCA2 gene encodes a 3,418-amino-acid nuclear
protein that shares little sequence homology with any other pro-
tein in human. BRCA2 comprises an N-terminal region, a central
region with eight BRC repeats, three tandem oligonucleotide/
oligosaccharide-binding folds (OB-folds), and a C-terminal
motif. The N-terminal region of BRCA2 is known to associate
with PALB2 (Oliver et al., 2009; Xia et al., 2006), whereas the
eight BRC repeats and the C-terminal motif are important for
the interaction with RAD51 (Carreira et al., 2009; Chen et al.,
1998; Mizuta et al., 1997; Pellegrini et al., 2002; Sharan et al.,
1997; Wong et al., 1997). The primary sequence of the three tan-
dem OB-folds of BRCA2 is highly conserved during evolution.
They associate with DSS1, a small scaffold protein that main-
tains the correct folding of the tandem OB-folds of BRCA2 (Mar-
ston et al., 1999; Yang et al., 2002). Moreover, the OB-folds of
BRCA2 are critical for the DNA repair function of BRCA2 as can-
cer-associated mutations have been identified in this region
(Guidugli et al., 2014; Karchin et al., 2008).
Previous study has shown that the OB-folds of BRCA2 are
capable of binding to single-stranded DNA (ssDNA) overhangs
generated at DSB ends (Yang et al., 2002). Here, we found that
the OB-folds of BRCA2 are important for targeting BRCA2 to
DNA lesions within 30 s. In such short time, DSB ends are un-
likely to be processed into ssDNA overhangs to host BRCA2.
Interestingly, poly(ADP-ribose) (PAR), a type of oligosaccharide
sharing basic component with ssDNA, is synthesized by PAR
polymerases (PARPs) immediately following DNA damage.
Accumulated evidence shows that poly(ADP-ribosyl)ation plays
an important role in DNA damage response (Gibson and Kraus,
2012; Hassa and Hottiger, 2008; Schreiber et al., 2006). Upon
DNA damage induction, PARP1, the founding member of
PARPs, rapidly detects DNA single-strand breaks (SSBs) or
DSBs, and is activated for PAR synthesis at DNA lesions within
a few seconds in response to DNA damage (Kim et al., 2005;
Luo and Kraus, 2012). Moreover, our previous study suggests
that the solo OB-fold motif is able to recognize iso-ADP-ribose,
the linkage between two ADP-ribose unites (Zhang et al.,
2014). Here, our results suggested that the tandem OB-folds
of BRCA2 recognize DNA-damage-induced PAR and target
BRCA2 to DNA lesions. BRCA2 and PARylation regulate the
recruitment of EXO1, which is one of themechanisms to regulate
DNA end resection and HR repair.
RESULTS
TheOB-FoldsMediate the Fast Recruitment of BRCA2 to
DNA Lesions
BRCA2 has been shown to relocate to DNA lesions in response
to DSBs. However, the kinetics of the recruitment of BRCA2
to DNA lesions is unclear. Here, we added a GFP tag at the N ter-
minus of BRCA2 and expressed GFP-BRCA2 in mouse embry-
onic fibroblasts (MEFs). Cells were treated with laser microirra-
diation, and the localization of GFP-BRCA2 was monitored
with live cell imaging. Interestingly, we found that BRCA2was re-
cruited to DNA lesions within 30 s, which is much faster than we
expected (Figures 1A and S1A). BRCA2 was also retained at
DNA lesions for prolonged time (Figure 1A). To validate the re-
sults, we used anti-BRCA2 antibody to examine the recruitment
of endogenous BRCA2 to DNA lesions in U2OS cells and ob-
tained similar kinetics (Figures 1B and S1B). Collectively, these
results suggest that BRCA2 quickly relocates to DNA lesions in
response to DNA damage.
Because BRCA2 contains several domains to interact with its
binding partners, we tagged each individual domain with GFP
and found that only the OB-folds of BRCA2 were able to relocate
to the sites of DNA damage (Figure 1C). We also measured the
kinetics of the recruitment. Similar to the full length of BRCA2,
the OB-folds were quickly recruited to DNA lesions within 30 s
and stayed for prolonged time (Figure 1D). Collectively, these
results suggest that the OB-folds mediate the recruitment of
BRCA2 to DNA lesions.
Fast Recruitment of BRCA2 to DNA Lesions Is Mediated
by PAR
Previous report shows that theOB-folds ofBRCA2bind to ssDNA
(Yang et al., 2002). However, the fast recruitment of BRCA2 indi-
cates that other binding partner similar to ssDNAmight be recog-
nized by the OB-folds of BRCA2. In response to DNA damage,
massive PAR is synthesized by PARPs in a few seconds (Kim
et al., 2005; Luo and Kraus, 2012). Similar to oligo-nucleotide,
PAR also contains phosphate groups, ribose and adenine. The
substrates of DNA-damage-induced PARylation is PARP1, the
enzyme itself, as well as histones at or adjacent to DNA lesions
(Kim et al., 2005; Luo and Kraus, 2012). Interestingly, PAR is a
type of oligosaccharide that can be recognized byOB-foldmotifs
(Zhang et al., 2014). Thus, we examined whether DNA-damage-
induced PARylation mediates the recruitment of the OB-folds
of BRCA2. We treated fibroblasts with olaparib, a potent
PARP1 inhibitor to suppress PAR synthesis, and found that theCrecruitment of the OB-folds of BRCA2 is significantly delayed
(Figures 2A and S2A). Similarly, the recruitment of endogenous
BRCA2 to DNA lesions was also significantly delayed in the pres-
ence of olaparib treatment (Figures 2B and S2B). Moreover, to
validate the results, we used an inducible I-SceI system gener-
ating a solo DNA DSB to examine the early recruitment of
BRCA2 (Li and Yu, 2013). Consistently, in the absence of PAR,
the recruitment of BRCA2 was remarkably delayed (Figure S2C).
Taken together, these results suggest that the fast recruitment
of BRCA2 is regulated by DNA-damage-induced PARylation.
Because most DNA-damage-induced PARylation is mediated
by PARP1 and PARP2 (Gibson and Kraus, 2012; Luo and Kraus,
2012), we knocked down PARP1 and PARP2, respectively (Fig-
ure 2C). In the absence of PARP1, but not PARP2, the early
recruitment of BRCA2 was significantly suppressed (Figure 2C),
suggesting that PARP1-mediated PARylation facilitates the early
recruitment of BRCA2. We confirmed the results in PARP1-defi-
cient MEFs (Parp1/ MEFs) (Figure 2C). Compared with that
in wild-type MEFs, the OB-folds of BRCA2 failed to be quickly
recruited to DNA lesions in Parp1/ MEFs. Collectively, these
results demonstrate that PAR mediates the fast recruitment of
BRCA2 to DNA lesions.
OB-Folds Domain of BRCA2 Binds to PAR In Vitro
Because PAR shares the basic components including ribose
sugar, phosphate, and adenosine with oligonucleotide, we ask
whether the OB-folds of BRCA2 interact with PAR. We first
generated and purified PAR from in vitro PARylation assay. It
has been shown that DSS1 is a binding partner of the OB-folds
and facilitates their folding of the OB-folds. Thus, we co-purified
the recombinant OB-folds/DDS1 complex and incubated with
PAR. We found that the OB-folds of BRCA2 directly bound to
PAR in an in vitro pull-down assay (Figure 3A). Previous studies
have shown that the integrity of the tertiary structure of the OB-
folds is required for the interaction with ssDNA (Yang et al.,
2002). Similarly, deleting part of the OB-folds or DSS1 alone
abolished the interaction, indicating that the folding of the OB-
folds is important for the interaction with PAR. In a reciprocal
pull-down experiment, PAR was also found to interact with the
OB-folds of BRCA2 (Figure 3B).
It has been shown that the OB-folds of BRCA2 recognize
ssDNA without sequence specificity (Yang et al., 2002). To
compare the binding affinity, we performed in vitro competition
assays using oligo(dA) that might be similar to PAR. In these as-
says, 50-mer oligo(dA) has been used to compete with 30 50-
mer PAR with increased molar ratio from 1:1 to 100:1. PAR and
oligo(dA) could compete with each other to bind the OB-folds of
BRCA2 (Figure 3C). Moreover, with electrophoretic mobility shift
assays (EMSAs), we quantitatively measured the affinities of
these interactions. The dissociation constant of both interaction
is between 100 and 200 nM (Figures 3D and 3E). Taken together,
these results suggest that the affinity between the OB-folds and
PAR is very similar to that between the OB-folds and ssDNA.
TheOB-Folds of BRCA2Associatewith PAR in Response
to DNA Damage In Vivo
Next, we ask whether BRCA2 interacts with PAR in vivo. Using
immunoprecipitation (IP) with anti-BRCA2 antibody and dotell Reports 13, 678–689, October 27, 2015 ª2015 The Authors 679
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Figure 1. The OB-Folds Mediate the Fast Recruitment of BRCA2 to DNA Lesions
(A) The relocation kinetics of GFP-BRCA2 to DNA damage sites. GFP-tagged BRCA2was expressed inMEFs, and the relocation kinetics wasmonitored in a time
course following laser microirradiation. For quantitative and comparative imaging, signal intensities at the laser line were converted into a numerical value using
Axiovision software (version 4.5). Normalized fluorescent curves from 20 cells were averaged. The error bars represent the SD. The scale bar represents 10 mm.
Signal intensities were plotted using Excel.
(B) The relocation kinetics of BRCA2 to DNA damage sites. U2OS cells were examined with laser microirradiation and stained with anti-BRCA2 and anti-gH2AX at
indicated time points. The scale bar represents 10 mm.
(C) Only the OB-folds of BRCA2 are able to relocate to the sites of DNA damage. Individual domain of BRCA2 was tagged with GFP and expressed in U2OS cells.
Cells were treated with laser microirradiation and were immunostained with anti-gH2AX. The scale bar represents 10 mm.
(D) The relocation kinetics of GFP-OB-folds to DNA damage sites. GFP-tagged BRCA2 OB-folds were expressed in MEFs, and the relocation kinetics were
monitored in a time course following laser microirradiation. The cells were co-stained with anti-gH2AX. The scale bar represents 10 mm.blotting with anti-PAR antibody, we found that BRCA2 associ-
ated with PAR in vivo (Figure 4A). Moreover, because DNA dam-
age induces PAR synthesis at the sites of DNA damage (Kim680 Cell Reports 13, 678–689, October 27, 2015 ª2015 The Authorset al., 2005; Luo and Kraus, 2012), the interaction between
PAR and BRCA2 was significantly increased following IR treat-
ment (Figure 4A). This interaction was further confirmed by
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Figure 2. Fast Recruitment of BRCA2 to DNA Lesions Is Mediated by PAR
(A) The effect of PARP inhibitor treatment on the recruitment of GFP-OB-folds to DNA damage sites. GFP-tagged BRCA2 OB-folds (GFP-OB-folds) were
expressed in U2OS cells, and the relocation kinetics were monitored in a time course following laser microirradiation. The cells were co-stained with anti-PAR.
The scale bar represents 10 mm.
(B) PARP inhibitor treatment suppresses the recruitment of BRCA2 to DNA damage sites. U2OS cells were examined with laser microirradiation and stained with
anti-BRCA2 and anti-PAR at indicated time points. The scale bar represents 10 mm.
(C) The effect of depletion of PARP1 or PARP2 on the recruitment of GFP-OB-folds to DNA damage sites. GFP-OB-folds were expressed in PARP1-deficient
MEFs (Parp1/) or U2OS cells depletion of PARP1 or PARP2 with siRNA. The relocation of GFP-OB-folds was monitored in a time course following laser
microirradiation. Depletion of endogenous PARP1 and PARP2 by siRNA was examined by western blotting. The scale bar represents 10 mm.
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Figure 3. OB-Folds Domain of BRCA2 Binds to PAR In Vitro
(A) The recombinant GST-fusion proteins were incubated with PAR. Protein-associated PAR was examined by glutathione agarose beads pull-down and dot
blotting with anti-PAR antibody. Recombinant GST and GST-CHFR were used as the negative and positive controls, respectively.
(B) The OB-folds domain of BRCA2 interacts with biotin-PAR. (Left) The recombinant GST-OB-folds were incubated with or without biotin-PAR. The interaction
was examined by streptavidin beads pull-down assay and western blotting with anti-GST antibody. (Right) The OB2 and OB3 of BRCA2 are essential for the
interaction with PAR. GST fusion proteins were incubated with biotin-PAR. The interaction was examined by streptavidin beads pull-down assay and western
blotting with anti-GST antibody. GST and GST-CHFR were used as the negative and positive controls, respectively.
(C) PAR competes out oligo(dA) (50-mer) to interact with the OB-folds domain of BRCA2. Biotinylated oligo(dA) or PAR was incubated with GST-OB-folds. Pull-
down assays were performed with GST beads (left) or streptavidin beads (right). 1, 10, and 100 indicate the molar ration between oligo(dA) and PAR in each
sample.
(D and E) Analysis of the affinity of the BRCA2 OB-folds to oligo(dA) (D) or PAR (E) by EMSA. EMSA reactions were carried out in the presence of 0.5 nM
radiolabeled oligo(dA) or PAR and varying amounts of BRCA2 OB-folds as indicated. To calculate dissociation constant (Kd), the percentage of radiolabeled
DNA-protein complexes was quantified and plotted against the quantity of protein. The data are the average of two independent saturation binding experiments.
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ciate with PAR in Response to DNADamage
In Vivo
(A and B) The in vivo interaction between BRCA2
and PAR was examined by co-IP (A) and recip-
rocal co-IP (B). U2OS cells were treated with 0 or
10 Gy of IR. Five minutes after IR, cells were lysed
and analyzed with indicated antibodies. Input or
IPed samples were analyzed by dot blotting (A) or
western blotting (B) with the indicated antibodies.
(C) BRCA2 itself is not PARylated in response to
IR. This panel is the same as (A) except that the
precipitation of co-IP was treated with or without
1% SDS.
(D) The in vivo interaction between BRCA2 and
PAR was examined by co-IP and reciprocal co-IP
in the presence or absence of olaparib (100 nM)
and IR treatment (10 Gy) with the indicated anti-
bodies. Irrelevant IgG was included as the IP
control.
(E) The cancer-associated missense mutations
surrounding or inside of the OB-folds abolish the
interaction with PAR. GFP-tagged OB-folds and
the indicated mutants were expressed in 293T
cells. Cell lysates were analyzed by the indicated
antibodies. The expression levels of exogenous
OB-folds proteins were examined by western
blotting with anti-GFP antibody.
(F) The OB-folds with cancer-associated muta-
tions fail to relocate to the sites of DNA damage.
GFP-tagged BRCA2 OB-folds mutant was ex-
pressed in MEFs, and the relocation was moni-
tored at 1 min following laser microirradiation. The
cells were co-stained with anti-gH2AX. The scale
bar represents 10 mm.reciprocal IP (Figure 4B). To exclude the possibility that the inter-
action between BRCA2 andPAR ismediated byDNA, we treated
samples with DNase I to digest DNA. Similar results were ob-
tained (Figure S3). In addition, to exclude the possibility that
BRCA2 itself was PARylated, we treated the precipitates with
1% SDS that abolished the non-covalent interactions. In the
presence of SDS, BRCA2 was dissociated with PAR (Figure 4C),
suggesting that BRCA2 itself is not PARylated in response to
DNAdamage.We also used olaparib to suppress PAR synthesis.
When PAR synthesis was suppressed by olaparib treatment,
BRCA2 no longer interacted with PAR following DNA damage
(Figure 4D). Taken together, these results suggest that BRCA2
recognizes PAR in vivo, especially when PAR is massively syn-
thesized following DNA damage.
Cancer-associated BRCA2 mutations have been identified
surrounding and inside of the OB-folds of BRCA2 (Guidugli
et al., 2014; Karchin et al., 2008). Next, we ask whether these
mutations regulate the interaction between the OB-folds of
BRCA2 and PAR. We analyzed three breast-cancer-associated
mutations: R2659K; G2724A; and S2988G. Among these patho-
genic mutations, R2659 locates in the helical domain just prior to
the OB1, G2724 is inside of the OB1, and S2988 is in the OB2 of
BRCA2. Interestingly, all three mutations abolished the interac-
tion between the OB-folds of BRCA2 and PAR (Figure 4E). More-Cover, all three mutations abolished the recruitment of the BRCA2
OB-folds to DNA lesions (Figure 4F).
BRCA2 and PARylation Regulate the Recruitment of
EXO1 and DNA End Resection
Because PAR mediates early recruitment of BRCA2 to DNA le-
sions, we explored the biological function of the PAR-dependent
recruitment of BRCA2 to DNA lesions. BRCA2 is known for
loading RAD51 to 30 ssDNA overhangs at DSB ends, which is
an essential step for RAD51-mediated strand invasion (Carreira
et al., 2009; Davies et al., 2001; Esashi et al., 2007; Jensen
et al., 2010; Liu et al., 2010; Pellegrini et al., 2002; Powell et al.,
2002; Thorslund et al., 2010; Yang et al., 2005a). However, 30
ssDNAoverhangs are unlikely to be processedwithin 30 s.More-
over, the kinetics of the recruitment of RAD51 was much slower
than that of BRCA2 (Figure S4A), suggesting that the early
recruitment of BRCA2 to DNA lesions is important for another
biological process. The first step of HR is DNA end resection.
A group of endo- and exo-nucleases including MRE11, CtIP,
and EXO1 function together to process DNA ends into 30 ssDNA
overhangs (Huertas, 2010; Longhese et al., 2010; Mimitou and
Symington, 2011; Raynard et al., 2008; Symington and Gautier,
2011). We ask whether early recruited BRCA2 plays a role in
DNA end resection by examining whether BRCA2 facilitatesell Reports 13, 678–689, October 27, 2015 ª2015 The Authors 683
Figure 5. BRCA2 and PARylation Regulate the Recruitment of EXO1
Depletion of BRCA2 or suppression of PAR synthesis abolishes the early
recruitment of EXO1 to DNA lesions. U2OS cells were treated with siBRCA2 or
olaparib; the relocation kinetics of GFP-EXO1 to the sites of DNA damage was
examined. The scale bar represents 10 mm. GFP fluorescence at the laser line
was converted into a numerical value (relative fluorescence intensity) using
Axiovision software (version 4.5). Normalized fluorescent curves from 20 cells
from three independent experiments were averaged. Signal intensities were
plotted using Excel. Error bars represent the SD.the loading of these nucleases to DNA ends. Among these nucle-
ases, MRE11 and EXO1 reach DNA lesions within 30 s (Figures 5
and S4B). However, the recruitment of CtIP is much slower
compared to that of MRE11 or EXO1 (Figure S4C), suggesting
that CtIP is unlikely to be regulated by early recruited BRCA2.
In U2OS cells lacking BRCA2, MRE11 was still recruited to the
sites of DNA damage within 30 s (Figure S4B). However, the
recruitment of EXO1 was significantly delayed in the absence
of BRCA2 (Figures 5 and S4D). Moreover, we treated cells with
olaparib to suppress early recruitment of BRCA2 to DNA lesions.
Lacking early recruited BRCA2, the early recruitment of EXO1
was also impaired (Figures 5, S4E, and S4F). Taken together,
our results indicate that BRCA2 facilitates the early recruitment
of EXO1.
Because EXO1 mediates DNA end resection, we ask whether
BRCA2 is also important for DNA end resection. We performed a
DNA damage end resection assay by examining the BrdU expo-
sure at DNA lesions in S phase (Figures 6A, S5A, and S5B). Usu-
ally, BrdU is incorporated into genomic DNA and buried in the
DNA double-strand helix, thus could not be detected by anti-
BrdU Ab. However, once DNA lesions occur and induce DNA
end resection, BrdU at 30 ssDNA overhangs is exposed and is
able to be detected by anti-BrdU following laser microirradiation
in an immunostaining assay (Figure 6A). We found that BrdU
started to be exposed from 10 min following DNA damage
(Figure 6B, upper panel). The exposure of BrdU at processed
DNA ends was regulated by EXO1 as the BrdU exposure at
DNA lesions was suppressed in cells lacking EXO1, which is
consistent with previous observations that EXO1 is required for
DNA end resection (Mimitou and Symington, 2011). Interestingly,
in BRCA2-deficient cells, the BrdU exposure at DNA lesions was
significantly delayed (Figures 6C and S5A). Similar results were
observed in cells with knockdown of BRCA2 (Figures 6B and
S5B). When BRCA2-deficient cells were reconstituted with
wild-type BRCA2, the kinetics of BrdU exposure at DNA ends
were restored (Figure 6C). However, when BRCA2-deficient cells
were reconstituted with the R2659K mutants that are defective684 Cell Reports 13, 678–689, October 27, 2015 ª2015 The Authorsfor PAR binding, the BrdU exposure at DNA lesions (Figure 6A)
and the recruitment of EXO1were also significantly delayed (Fig-
ure S4D). Moreover, when cells were treated with olaparib to
suppress PARylation, the BrdU exposure was also remarkably
delayed (Figure 6D), suggesting that the early recruited BRCA2
by PAR might be important for EXO1-mediated DNA end
resection.
DISCUSSION
In this study, we found that the tandem OB-folds of BRCA2 is a
PAR-binding module. DNA-damage-induced PARylation medi-
ates the fast recruitment of BRCA2 to DNA lesions, which is
important for the recruitment of EXO1 and EXO1-dependent
DNA end resection. With both in vitro and in vivo analyses, we
found that the OB-folds recognize DNA-damage-induced PAR
at DNA lesions. Because PAR is an oligo-nucleotide-like polymer
sharing the basic components with oligo-nucleotide, it is likely
that the OB-folds use the same binding sites to recognize both
ssDNA and PAR. Our study shows that the affinity between the
OB-folds and PAR is similar to that between the OB-folds and
ssDNA. Previous study demonstrates that three tandem OB-
folds are organized to form a single domain and interacts with
ssDNA at multiple sites (Yang et al., 2002). Here, we also show
that several cancer-associated mutations near or inside of the
OB-folds abolish the interaction between PAR and the OB-folds,
suggesting that tertiary structure of the BRCA2 OB-folds plays a
key role for the interaction. Future structural analysis will reveal
the details of the interaction between PAR and the OB-folds.
The function of the interaction between PAR and the OB-folds
is to quickly relocate BRCA2 to DNA lesions. It has been reported
that PARPs can use up to 90% cellular NAD+ to synthesize
massive amount of PAR at DNA lesions (Berger et al., 1983; Yu
et al., 2002). Thus, ample amount of PAR is sufficient to recruit
BRCA2 to the sites of DNA damage. Moreover, PARylation oc-
curs within a few seconds following DNA damage (Kim et al.,
2005; Luo and Kraus, 2012), which is consistent with the kinetics
of the early recruitment of BRCA2. Importantly, direct suppres-
sion of PAR synthesis by PARP inhibitor remarkably delays the
recruitment of BRCA2. And we have used two different systems
to validate the results. Thus, these lines of evidence suggest
that DNA-damage-induced PARylation mediates the fast wave
recruitment of BRCA2 to the sites of DNA damage. PARylation
is also a short-lived posttranslational modification during DNA
damage response. Within a few minutes, DNA-damage-induced
PAR is hydrolyzed by PARG and other PAR degradases
(D’Amours et al., 1999; Kim et al., 2005; Luo and Kraus, 2012).
Thus, DNA-damage-induced PARylation mediates early and
fast recruitment of BRCA2. Along with PAR degradation, DNA
end resection is started and ssDNA overhangs are generated
by resection enzymes. Because the OB-fold of BRCA2 also rec-
ognizes ssDNA, the 30 ssDNA overhangs are important for the
retention of BRCA2 at DNA lesions. Consistently, we found two
waves of BRCA2 at DNA lesions (Figures 1A and 1B). The first
wave recruitment of BRCA2 is clearly mediated by PAR. With
PAR degradation, BRCA2 is released and recognizes the ssDNA
overhangs. This two-wave retention at DNA lesions also occurs
in other DNA damage repair machineries, such as BRCA1 (Li and
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(legend on next page)
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Yu, 2013), which indicates the potentially different biological
functions during this two-wave retention because these repair
machineries recognize different partners in each stage.
Previously, studies have demonstrated that the second wave
of BRCA2 retention is to load RAD51 to DNA lesions and facili-
tates RAD51/ssDNA filament invasion into sister chromatids
(Carreira et al., 2009; Davies et al., 2001; Esashi et al., 2007; Jen-
sen et al., 2010; Liu et al., 2010; Pellegrini et al., 2002; Powell
et al., 2002; Thorslund et al., 2010; Yang et al., 2005a). Our study
also verified that the recruitment kinetics of RAD51 are consis-
tent with the timing of the second wave of BRCA2 at DNA le-
sions. Here, we have dissected the biological function of the first
wave of BRCA2 that is mediated by DNA-damage-induced PAR.
We found that BRCA2 is important for DNA end resection by
facilitating EXO1, a key resection enzyme, to DNA lesions. How-
ever, we did not detect the direct interaction between BRCA2
and EXOI, suggesting that BRCA2 does not directly recruit
EXOI to the site of DNA damage. It is possible that BRCA2
sets up the local environment for the recruitment of EXO1. The
analog situation is the RNF8-mediated protein ubiquitination. In
the previous studies, we and others have shown that RNF8 me-
diates the recruitment of BRCA1 (Huen et al., 2007; Kolas et al.,
2007; Mailand et al., 2007;Wu et al., 2009). However, RNF8 does
not directly interact with BRCA1 for the recruitment. Instead,
RNF8 mediates histone ubiquitination that is recognized by the
BRCA1-associated partner RAP80. The interaction between
ubiquitin and the ubiquitin-binding domain of RAP80 mediates
the recruitment of BRCA1. Similarly, BRCA2 is quickly recruited
by PAR and is likely to modify local chromatin at the sites of DNA
damage for the recruitment of EXO1. Recent studies indicate
that EXO1 has several binding partners such as PCNA, MSH2,
MSH3, etc. (Dherin et al., 2009; Liberti et al., 2011; Schmutte
et al., 2001; Tishkoff et al., 1997; Tran et al., 2001). Especially,
it has been shown that PCNA mediates the recruitment of
EXO1 (Chen et al., 2013). Thus, it is likely that BRCA2 may regu-
late PCNA for the recruitment of EXO1.
Moreover, it has been shown that the MRN complex is
involved in the recruitment of EXO1 in budding yeast (Nicolette
et al., 2010). However, we did not observe that the early recruit-
ment of EXO1 is regulated by the MRN complex in U2OS cells.
The recruitment mechanism of EXO1 in budding yeast could
be very different from mammals. Especially, yeast does not
have protein poly-ADP-ribosylation and PARPs. And the PAR-
binding module in NBS1 is degenerated in yeast. The kinetics
of the recruitment of DNA damage response factors in yeast
remain elusive. It is possible that the early and fast recruitment
mechanism mediated by poly-ADP-ribosylation occurs during
the evolution, which becomes more important for mammals to
keep the genomic stability.Figure 6. BRCA2 and PARylation Are Important for DNA End Resectio
(A) Schematic diagram of DNA damage end resection assay.
(B) Depletion of EXO1 or BRCA2 suppresses DNA end resection. U2OS cells tre
stained with anti-BrdU and anti-gH2AX at indicated time points. The scale bar r
examined by western blotting.
(C) BRCA2 is important for EXO1-mediated DNA end resection. Capan1 cells an
microirradiation and stained with anti-BrdU and anti-gH2AX at indicated time po
(D) U2OS cells were treated with olaparib. The scale bar represents 10 mm. The
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PALB2 via an N-terminal region (Oliver et al., 2009; Xia et al.,
2006). It has been shown that PALB2 facilitates the recruitment
of BRCA2 to DNA lesions as well (Xia et al., 2006, 2007). How-
ever, the N terminus of BRCA2 per se could not be recruited to
the sites of DNA damage (Figure 1C), suggesting that only the
interaction between PALB2 and BRCA2 is insufficient to mediate
the recruitment of BRCA2. Alternatively, PALB2 may interact
with BRCA2 through multiple contacts. But like BRCA2 and
RAD51, PALB2 is also an ssDNA-binding protein and facilitates
the loading RAD51 onto the ssDNA overhangs (Dray et al.,
2010). PALB2 even directly interacts with RAD51 (Park et al.,
2014). Thus, PALB2 is likely to play a key role for the second
wave of BRCA2 at DNA lesions. PALB2, BRCA2, and RAD51
may form a complex that is important for RAD51/ssDNA filament
formation.
Taken together, our study demonstrates a molecular mecha-
nism of BRCA2 in DNA damage repair, which is helpful for under-
standing the BRCA2 mutation-induced tumorigenesis.
EXPERIMENTAL PROCEDURES
GFP-BRCA2 and GFP-ExoI plasmids were a gift from laboratory of Drs. Bing
Xia and Zhongsheng You, respectively. CtIP, MRE11, and N terminus (aas
1–300); pre-BRC (aas 1–933); BRC (aas 934–2,467); OB-folds (aas 2,477–
3,196); or C terminus (aas 3,163–3,418) of BRCA2 were cloned into pEGFP-
C1 vector. The PAR-binding mutants and siRNA-resistant form of BRCA2
OB-folds (aas 2,477–3,196) were generated using the QuikChange site-
directed mutagenesis kit (Stratagene).
The siRNA sequences targeting PARP1, PARP2, BRCA2, and Exo1 are
50-CAAAGUAUCCCAAGAAGUUdTdT-30, 50-GGAGAAGGAUGGUGAGAAAd
TdT-30, 50-GAAGAACAAUAUCCUACUAdTdT-30, and 50-CAAGCCUAUUCUC
GUAUUUdTdT-30, respectively. The siRNAs were transfected into cells using
oligofectamine (Invitrogen) according to manufacturer’s instructions.
Anti b-actin, anti-biotin, anti-EXO1, and anti-GFP antibodies were
purchased from Sigma. Anti-PARP1, anti-PARP2, and anti-BRCA2 anti-
bodies were purchased from Millipore. Anti-PAR antibody was purchased
from Trevigen. Anti-Rad51 and phospho-H2AX (g-H2AX) were generated
as described previously (Ward et al., 2003; Yamane et al., 2002; Yu et al.,
2003).
Baculoviruses and Recombinant Protein Purification from Insect
Cells
For baculovirus, DNA fragment containing the BRCA2 OB-folds (aas 2,477–
3,196) and full-length DSS1 were subcloned into pFastBac vector with
or without a GST tag, and baculoviruses were generated according to
manufacturer’s instructions. After cells were infected with combinations
of baculoviruses for 48 hr, the SF9 cells were harvested, washed with
PBS, and lysed with 10 ml ice-cold NETN-100 (0.5% NP-40, 2 mM
EDTA, 100 mM Tris-HCl [pH 7.5], and 100 mM NaCl) buffer. The soluble
fraction was incubated with 0.5 ml glutathione-Sepharose beads (for GST
tag). The protein/complexes were affinity purified according to manufac-
turer’s instructions.n
ated with siEXO1 or siBRCA2 were examined with laser microirradiation and
epresents 10 mm. Depletion of endogenous EXO1 and BRCA2 by siRNA was
d Capan1 reconstituted with wild-type BRCA2 cells were examined with laser
ints. The scale bar represents 10 mm.
end resection was analyzed as same as in (B).
Synthesis, Purification, and Fractionation of PAR
His-tagged human PAR polymerase1 (PARP1) was expressed in bacteria and
purified by Ni-NTA affinity resin. PAR was synthesized and purified as
described previously except for the following modifications (Fahrer et al.,
2007). PAR was synthesized in a 20-ml incubation mixture containing
100 mM Tris-HCl (pH 7.8), 10 mM MgCl2, 1 mM NAD
+, 10 mM DTT, 60 mg
calf thymus histone, 50 mg octameric oligonucleotide GGAATTCC, and 2 mg
PARP1. To generate biotinyl-PAR, 10 mM biotinyl-NAD+ (Trevigen) was
included in the reaction. The mixture was incubated at 30C for 60 min and
stopped by addition of 20 ml ice-cold 20% TCA. Oligo DNA was removed
by DNase I, and proteins were digested by proteinase K. Purified PAR was
fractionated according to chain length by anion exchange HPLC protocol as
described previously (Fahrer et al., 2007).
Laser Microirradiation and Imaging of Cells
U2OS cells and MEFs with or without transfection of indicated plasmids were
plated on glass-bottomed culture dishes (MatTek). Laser microirradiation was
performed using an IX 71 microscope (Olympus) coupled with the MicroPoint
Laser Illumination and Ablation System (Photonic Instruments). A 337.1-nm
laser diode (3.4 mW) transmits through a specific dye cell and then yields
365-nm wavelength laser beam that is focused through 603 UPlanSApo/
1.35 oil objective to yield a spot size of 0.5–1 mm. Cells were exposed to the
laser beam for about 3.5 ns. The pulse energy is 170 mJ at 10 Hz. Images
were taken by the same microscope with CellSens software (Olympus).
For quantitative and comparative imaging, signal intensities at the laser line
were converted into a numerical value using Axiovision software (version 4.5).
To compensate for nonspecific fluorescent bleaching during the repeated im-
age acquisition, in every image, we first measured the average fluorescent in-
tensity (at the laser line) as a function of time and then divided it by the average
fluorescent intensity measured elsewhere in the cell (background) as a func-
tion of time. To get normalized GFP-tagged proteins accumulation curve for
each cell, the fluorescent intensity (RF) at the laser line was calculated by
the following formula: RF(t) = [(I–Ipre IR)/(Imax–Ipre IR)], where Ipre IR is the
fluorescent intensity of the laser line region before irradiation and Imax repre-
sents the maximum fluorescent intensity at the laser line. Normalized fluores-
cent curves from 20 cells were averaged. The error bars represent the SD. The
scale bar represents 10 mm. Signal intensities were plotted using Excel.
EMSA
The affinity between the OB-folds of BRCA2 and PAR or oligo(dA) was
measured by electrophoretic mobility shift assay (EMSA) essentially as
described (Hellman and Fried, 2007; Yang et al., 2005b). Briefly, the BRCA2
OB-folds recombinant protein was incubated with 32P-labeled DNA or PAR
probes (20,000 cpm; 0.5 nM) in a 30-ml reaction containing buffer A (50 mM
Tris-HCl [pH 8.0], 50 mM NaCl, 1 mM DTT, 0.05% NP-40, 100 ng poly (dI-
dC), and 6% glycerol) for 30 min at 4C. The reaction mixtures were electro-
phoresed at 4C on 5% non-denaturing polyacrylamide gel in a buffer contain-
ing 7 mM Tris-HCl (pH 7.4), 3 mM boric acid, and 1 mM EDTA. Gels were dried
and autoradiographed. The apparent dissociation constant (Kd) was esti-
mated as the protein concentration at which half of the radiolabeled DNA
probe was shifted in an EMSA essentially as described (Yang et al., 2005b).
Dot Blotting
Recombinant proteins (10 pmol) were conjugated to glutathione beads and
incubated with PAR (100 pmol; calculated as the ADP-ribose unit) for 2 hr at
4C. Beadswere washedwith NETN-100 buffer for four times. GST-fusion pro-
teins were eluted from beads by glutathione and spotted onto a nitrocellulose
membrane. The membrane was blocked with TBST buffer (0.15 M NaCl,
0.01 M Tris-HCl [pH 7.4], and 0.1% Tween 20) supplemented with 5% milk,
extensively washed with TBST. After drying in the air, the membrane was
examined by anti-PAR antibody.
GST Fusion Protein Expression and Pull-Down Assay
GST fusion proteins were expressed in Escherichia coli and purified using
standard procedures. Purified GST fusion proteins (1 pmol) were incubated
with biotin-labeled PAR (5 pmol) and streptavidin beads for 2 hr at 4C.
After washing with NETN-100 buffer four times, samples were boiled inCSDS-sample buffer and elutes were analyzed by western blotting with anti-
GST antibody.
Cell Culture, Cell Lysis, IP, and Western Blotting
Human cancer cell lines were maintained in RPMI 1640mediumwith 10% fetal
calf serum and cultivated at 37C in 5% CO2 (v/v). For ionizing radiation, cells
were irradiated by using JL Shepherd 137Cs radiation source at indicated
doses. Cells were lysed with NETN-100 buffer containing 10 mM NaF and
50mM b-glycerophosphate. IP and western blotting were performed following
standard protocol.
Flow Cytometry
Cells were trypsinized and washed with PBS twice and centrifuged (800 rpm)
at 4C. Cells were fixed in 500 ml ice-cold 70% ethanol overnight at 4C. Fixed
cells were centrifuged at 500 rpm at 4C for 10 min and suspended in 500 ml
PBS containing 50 ml of 50 mg/ml propidium iodide (Sigma) and 10 ml of
5 mg/ml RNase for 45–60 min at 4C. Flow cytometric analysis was done within
24 hr of propidium iodide staining on a Beckman-Coulter Epics XL. EXPO32
software was used for optimum analysis of cell cycle (G1, G2, and S phases).
PAR Binding Assays
Approximately 2 mM (53) or 0.4 mM (13) of each recombinant protein were
incubated with 10 mMPAR and 30 ml glutathione agarose in the buffer contain-
ing 10 mM NaH2PO4 (pH 7.5) and 100 mM NaCl. After incubation for 1 hr at
room temperature, the beads were extensively washed with PBS, and bound
proteins were released by adding 30 ml sample buffer (150 mM Tris-HCl, 10%
SDS, and 10 mMEDTA) followed by heating at 80C for 10 min. Two-microliter
aliquots of samples were dot blotted onto nitrocellulose membranes. After in-
cubation for 1 hr at 60C, membranes were subjected to dot-blotting analysis
with anti-PAR antibodies.
Immunofluorescence Staining
Cells grown on coverslips were fixed with 3% paraformaldehyde for 20 min
and permeabilized with 0.5% Triton X-100 in PBS for 5 min at room tempera-
ture. Samples were blocked with 5% goat serum and then incubated with pri-
mary antibody for 60 min. Samples were washed three times and incubated
with secondary antibody for 30 min. The coverslips were mounted onto glass
slides and visualized by a fluorescence microscope.
DNA Damage End Resection Assay
Cells were grown on 15-mm glass-bottom cell culture dish such that they are
rapidly dividing (usually 50% confluent). Cells were incubated in 10 mM BrdU
for 24 hr. Cells were exposed to the laser beam for about 3.5 ns. The pulse
energy is 170 mJ at 10 Hz. Cells were immediately pretreated with ice-cold
NETN-300 buffer (0.5% NP-40, 2 mM EDTA, 100 mM Tris-HCl [pH 7.5], and
300 mM NaCl) and fixed with 3% paraformaldehyde for 30 min. Immunostain-
ing was performed as described before (Zhang et al., 2009).
Inducible DSB System
A DSB system was established before (Li and Yu, 2013). Briefly, U2OS cells
stably expressing RFP-I-SceI-GR were used in this system. The synthetic
glucocorticoid ligand TA (Sigma) was added (0.1 mM) to induce the transloca-
tion of RFP-I-SceI-GR from cytoplasm into nucleus, which generated a solo
DSB. The kinetics of the recruitment of DNA damage repair factors were exam-
ined. Images were taken using the same microscope of laser microirradiation
with the CellSens software (Olympus).
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